← All organizations

Ironshore Pharmaceuticals and Development, Inc

For profit

Also known as: Ironshore Pharmaceuticals and Development, Inc | IRONSHORE PHARMS

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Sep 13, 2024

Timeline

2000s

Jun 1, 2008
Ironshore Pharmaceuticals and Development, Inc— Founded

2010s

Aug 8, 2018
methylphenidate— NDA Secondary Org

Drugs by trial phase (2 distinct, 7 trials)

Phase 3 (1 own, 0 via acquisition)

methylphenidate

Phase 2 (1 own, 0 via acquisition)

dextroamphetamine

Indications

Studied for

Marketed drugs (1)

methylphenidate

Recent trials (7)

NCT06431256Lead sponsorPhase 3Sep 13, 2024
NCT02884544Lead sponsorPhase 2Aug 1, 2016
NCT02520388Lead sponsorPhase 3Aug 1, 2015
NCT02493777Lead sponsorPhase 3Jul 1, 2015
NCT02255513Lead sponsorPhase 3May 1, 2014
NCT01907360Lead sponsorPhase 1/Phase 2Aug 1, 2013
NCT01886469Lead sponsorPhase 1/Phase 2Jul 1, 2013

Details

Founded: Toronto, CA Jun 1, 2008
Last known activity: Sep 13, 2024